ABSORB II: Comparable Clinical Outcomes Noted with ABSORB Scaffold and XIENCE Stents

Summary

Results from ABSORB II [Serruys PW et al. Lancet. 2014], the first study to compare an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent, demonstrated similar 1-year clinical outcomes in patients with coronary artery disease.

  • Coronary Artery Disease
  • Cardiology Clinical Trials
  • Interventional Techniques & Devices
  • Coronary Artery Disease
  • Cardiology Clinical Trials
  • Cardiology
  • Interventional Techniques & Devices
View Full Text